01 1Wuxi Fortune Pharmaceutical
01 1CANTHARIDIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-06-10
Pay. Date : 2023-09-28
DMF Number : 37369
Submission : 2023-04-14
Status : Active
Type : II
20
Wuxi Fortune Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CANTHARIDIN, with a corresponding US DMF Number 37369.
Remarkably, this DMF maintains an Active status since its submission on April 14, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 10, 2025, and payment made on September 28, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
